Levofloxacin Ibigen (Levofloxacin)

Levofloxacin works by binding to bacterial DNA gyrase and topoisomerase IV, enzymes that control DNA supercoiling and replication. Inhibiting these enzymes prevents bacterial DNA synthesis and transcription, leading to rapid bacterial cell death and resolution of the infection.

The dose of Levofloxacin Ibigen is determined by the prescribing clinician based on the type and severity of the infection, the patient’s renal function, weight, and other clinical factors. No fixed regimen is provided here; the prescriber sets the appropriate dosing schedule.

Levofloxacin falls under an unknown pregnancy category, and its safety for the fetus or nursing infant has not been established. It should only be used during pregnancy or lactation when the potential benefit justifies the possible risk, and after a thorough risk‑benefit assessment by the healthcare provider.

To order Levofloxacin Ibigen, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Levofloxacin and moxifloxacin are both fluoroquinolones, but levofloxacin has a broader spectrum against Gram‑negative organisms and is often preferred for urinary tract infections, whereas moxifloxacin offers enhanced activity against atypical respiratory pathogens. Choice between them depends on the infection site, bacterial susceptibility, patient tolerance, and clinician judgment.

Levofloxacin Ibigen should be stored at temperatures below 25 °C. Keep the vial in its original packaging, protect it from direct light and moisture, and avoid freezing. Do not use the product if the solution appears discolored or contains particles.

Levofloxacin Ibigen is administered intravenously by slow infusion, typically over 30–60 minutes, under the supervision of a qualified healthcare professional. The exact infusion rate and duration are determined by the prescribing physician based on the patient’s condition and clinical guidelines.

Serious risks include tendon rupture or tendinitis, especially in older adults or those on corticosteroids; QT interval prolongation that can lead to life‑threatening arrhythmias; severe allergic reactions such as anaphylaxis or Stevens‑Johnson syndrome; Clostridioides difficile‑associated colitis; and peripheral neuropathy. Patients should be instructed to seek immediate medical attention if these symptoms occur.

Levofloxacin Ibigen is contraindicated in patients with a known hypersensitivity to levofloxacin, other fluoroquinolones, or any component of the formulation. It should also be avoided in individuals with a history of tendon disorders related to fluoroquinolone use, uncontrolled cardiac arrhythmias, or severe electrolyte imbalances that predispose to QT prolongation.